Intro

In today’s episode, we discuss how to approach AML treatment for patients who are unfit for intensive therapy.

Episode contents:

- How do we assess fitness for intensive AML?

- What are options for patients who are unfit for intensive chemotherapy for AML?

- What are important genetic mutations are important to check for?

- What are the key trials that inform our management in this space?

- How do we dose venetoclax?

- How do we sequence the available agents?

****Get paid to participate in market research surveys: https://affiliatepanel.members-only.online/FOC_24?utm_campaign=FOC&utm_source=email&utm_medium=email

** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes

Love what you hear? Tell a friend and leave a review on our podcast streaming platforms!

Twitter: @TheFellowOnCall

Instagram: @TheFellowOnCall

Listen in on: Apple Podcast, Spotify, and Google Podcast